Literature DB >> 25728765

Parent-infant art psychotherapy: a creative dyadic approach to early intervention.

Victoria Gray Armstrong1, Rosie Howatson.   

Abstract

Art psychotherapy involves the use of the image-making process within a therapeutic relationship to help clients explore and communicate feelings and experiences. This article explores whether art psychotherapy groups can be an effective intervention for parent-infant dyads who may be involved with social work and health teams due to concerns about their relationship, possibly due to postnatal depression or attachment difficulties. We describe a model of parent-infant art psychotherapy groups and examine some of the key themes in this intervention alongside vignettes of case work and quantitative and qualitative evidence from the evaluations of two such groups. We believe that the Create Together group demonstrates how knowledge from research into infant mental health and attachments, together with an understanding of the creative process, can be applied in practice to offer a successful early intervention.
© 2015 Michigan Association for Infant Mental Health.

Entities:  

Mesh:

Year:  2015        PMID: 25728765     DOI: 10.1002/imhj.21504

Source DB:  PubMed          Journal:  Infant Ment Health J        ISSN: 0163-9641


  3 in total

1.  The Experiences of Parents and Infants Using a Home-Based Art Intervention Aimed at Improving Wellbeing and Connectedness in Their Relationship.

Authors:  Victoria Gray Armstrong; Josephine Ross
Journal:  Front Psychol       Date:  2022-05-17

2.  Art as a Therapeutic Tool in Depressive Disorders: a Systematic Review of the Literature.

Authors:  Fernando Mateus Viégas Brandão; Carolina Ventura Silva; Kleber Roberto da Silva Gonçalves de Oliveira; Janari da Silva Pedroso
Journal:  Psychiatr Q       Date:  2019-12

Review 3.  The Psychological Recovery of Patients in the Context of Virtual Reality Application by a Complementary Medicine Scheme Based on Visual Art.

Authors:  Bolin Li; Meilin Shen
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-19       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.